OncoMed Pharmaceuticals Inc Contracts & Agreements

Contingent Value Rights Agreement, by and between OncoMed Pharmaceuticals, Inc. and Computershare Inc., as rights agent (Filed With SEC on March 15, 2019)

Form of Stockholder Support Agreement (Filed With SEC on March 15, 2019)

Agreement and Plan of Merger and Reorganization, dated December 5, 2018, by and among Mereo BioPharma Group plc, Mereo US Holdings Inc., Mereo MergerCo One Inc. and OncoMed... (Filed With SEC on December 6, 2018)

Form of Stockholder Support Agreement, by and between Mereo BioPharma Group plc and certain stockholders of OncoMed Pharmaceuticals, Inc (Filed With SEC on December 6, 2018)

Form of Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and certain officers and directors of Mereo BioPharma Group plc (Filed With SEC on December 6, 2018)

Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and Novartis Pharma AG (Filed With SEC on December 6, 2018)

Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and Invesco Asset Management Limited, as agent for and on behalf of its discretionary managed client,... (Filed With SEC on December 6, 2018)

Form of CVR Agreement (Filed With SEC on December 6, 2018)

Amendment 6 to the Collaboration and Option Agreement, dated June 13, 2018, by and between the registrant and Bayer Pharma AG (Filed With SEC on August 2, 2018)

Non-Employee Director Compensation Policy, adopted August 28, 2013, as amended October 14, 2013, February 28, 2014, June 24, 2015, and March 1, 2018 (Filed With SEC on May 8, 2018)

Letter Agreement re: Your Resignation of Employment and Board Positions, dated January 1, 2018, by and between the registrant and Paul Hastings (Filed With SEC on March 9, 2018)

Form of Retention Bonus Agreement for officers (Filed With SEC on March 9, 2018)

Amendment No. 3 to the Multi-Product License Agreement, dated August 26, 2016, by and between the registrant and Lonza Sales AG (Filed With SEC on November 2, 2017)

AMENDMENT 5 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on March 9, 2017)

THIRD AMENDMENT TO LEASE (Filed With SEC on March 9, 2017)

AMENDMENT 4 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on November 1, 2016)

OncoMed Pharmaceuticals, Inc. 5,500,000 Shares of Common Stock UnderwritingAgreement (Filed With SEC on August 23, 2016)

AMENDMENT 3 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on March 10, 2016)

(Signature Page Follows) (Filed With SEC on March 10, 2016)

AMENDMENT NO. 2 to the Multi-Product License Agreement dated 22 August 2012 between LONZA SALES AG and ONCOMED PHARMACEUTICALS, INC 1 (Filed With SEC on November 5, 2015)

ONCOMED PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Approved by the Board of Directors on August 28, 2013, as amended October 14, 2013, February 28, 2014 and... (Filed With SEC on August 10, 2015)

AMENDMENT NO. 1 to the Multi-Product LicenseAgreement dated 22 August 2012 between LONZA SALES AG and ONCOMED PHARMACEUTICALS, INC 1 (Filed With SEC on March 12, 2015)

ONCOMED PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Approved by the Board of Directors on August 28, 2013, as amended October 14, 2013 and February 28, 2014 (Filed With SEC on March 18, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 3, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 3, 2013)

ONCOMED PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Approved by the Board of Directors on August 28, 2013, as amended October 14, 2013 (Filed With SEC on November 13, 2013)

AMENDMENT 2 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on November 13, 2013)

ONCOMED PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Approved by the Board of Directors on August 28, 2013 (Filed With SEC on September 3, 2013)

[] Shares of Common Stock ONCOMED PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on July 8, 2013)

ONCOMED PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 8, 2013)

ONCOMED PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 3, 2013)

ONCOMED PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on July 3, 2013)

ONCOMED PHARMACEUTICALS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on July 3, 2013)

ONCOMED PHARMACEUTICALS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT PAUL HASTINGS (Filed With SEC on July 3, 2013)

Form of Supplemental Lock-up Agreement (Filed With SEC on July 3, 2013)

Page 1of 3 (Filed With SEC on October 25, 2012)

AMENDMENT 1 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on October 25, 2012)

COLLABORATION AGREEMENT between LONZASALES AG and ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on October 25, 2012)

MULTI-PRODUCT LICENSE AGREEMENT between LONZASALES AG and ONCOMED PHARMACEUTICALS, INC. INDEX (Filed With SEC on October 25, 2012)

RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND SMITHKLINE BEECHAM CORPORATION DECEMBER 7, 2007 TABLE OF... (Filed With SEC on July 5, 2012)

AMENDMENT NO. 1 TO THE RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT (Filed With SEC on July 5, 2012)

COLLABORATION AND OPTION AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND BAYER SCHERING PHARMA AG DATED JUNE 15, 2010 TABLE OF CONTENTS (Filed With SEC on July 5, 2012)

SUBSCRIPTION AND LICENSE AGREEMENT (Filed With SEC on July 5, 2012)

ONCOMED PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on July 3, 2012)

800Chesapeake Drive Redwood City, CA 94063 Phone: 650 ###-###-#### Fax: 650 ###-###-#### www.oncomed.com (Filed With SEC on June 15, 2012)

1 800Chesapeake Drive Redwood City, CA 94063 Phone: 650 ###-###-#### Fax: 650 ###-###-#### www.oncomed.com (Filed With SEC on June 15, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 11, 2012)

AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on May 11, 2012)

PLAIN ENGLISH WARRANT (Filed With SEC on May 11, 2012)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 11, 2012)

ONCOMED PHARMACEUTICALS, INC. AMENDMENT AND CONSENT (Filed With SEC on May 11, 2012)

RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND SMITHKLINE BEECHAM CORPORATION DECEMBER 7, 2007 TABLE OF... (Filed With SEC on May 11, 2012)

AMENDMENT NO. 1 TO THE RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT (Filed With SEC on May 11, 2012)

COLLABORATION AND OPTION AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND BAYER SCHERING PHARMA AG DATED JUNE 15, 2010 TABLE OF CONTENTS (Filed With SEC on May 11, 2012)

SUBSCRIPTION AND LICENSE AGREEMENT (Filed With SEC on May 11, 2012)

APPENDIX 4.3(a) COMMERCIAL LICENSE REQUEST FORM (To be completed for each Commercial Target) (Filed With SEC on May 11, 2012)

LICENSE AGREEMENT WITH CANCER STEM CELL GENOMICS, INC. MICHIGAN FILES 1819, 1876 AND 1980 TECHNOLOGY (Filed With SEC on May 11, 2012)

Amendment Number 1 to License Agreement Regents of The University ofMichigan & Cancer Stem Cell Genomics, Inc. University of Michigan Files 1819, 1876, 1980, 2237, 2629, 2705 (Filed With SEC on May 11, 2012)

Amendment Number 2 to License Agreement Regents of The University ofMichigan & OncoMed Pharmaceuticals, Inc. (Filed With SEC on May 11, 2012)

AMENDMENT NO. 3 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)

Amendment No. 4 to License Agreement between the Regents of The University of Michigan and OncoMed Pharmaceuticals,Inc. (Filed With SEC on May 11, 2012)

AMENDMENT NO. 5 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)

AMENDMENT NO. 6 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)

MEMORANDUM OF UNDERSTANDING (Filed With SEC on May 11, 2012)

LEASE (Filed With SEC on May 11, 2012)

FIRST AMENDMENT TO LEASE (Filed With SEC on May 11, 2012)

SECOND AMENDMENT TO OFFICE LEASE (Filed With SEC on May 11, 2012)

OncoMed Pharmaceuticals, Inc. Stock Incentive Plan (As Adopted and Effective August 16,2004 and as Amended) TABLE OF CONTENTS (Filed With SEC on May 11, 2012)

ONCOMED PHARMACEUTICALS, INC. STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on May 11, 2012)

OncoMed Pharmaceuticals, Inc. 265 N. Whisman Road Mountain View, CA 94043 (Filed With SEC on May 11, 2012)

Cancer Stem Cell Genomics, Inc. (Filed With SEC on May 11, 2012)

800 ChesapeakeDrive Redwood City, CA 94063 Phone: 650 ###-###-#### Fax: 650 ###-###-#### www.oncomed.com (Filed With SEC on May 11, 2012)

OncoMed Pharmaceuticals Inc. (OMPI) (Filed With SEC on May 11, 2012)

- 1 - (Filed With SEC on May 11, 2012)

SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on May 11, 2012)

800 ChesapeakeDrive Redwood City, CA 94063 Phone: 650 ###-###-#### Fax: 650 ###-###-#### www.oncomed.com (Filed With SEC on May 11, 2012)

Category

Industry

Companies

Contracts

OncoMed Pharmaceuticals Inc Contracts & Agreements